1 November 2018 | Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT
| Kessler, D; Burns, A; Tallon, D; et al. |
19 July 2022 | A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study
| Gamble, LD; Parker, S; Quinn, C; et al. |
29 June 2017 | Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.
| Webster, L; Groskreutz, D; Grinbergs-Saull, A; et al. |
30 July 2020 | Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
| Livingston, G; Huntley, J; Sommerlad, A; et al. |
1 May 2017 | Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.
| Webster, L; Groskreutz, D; Grinbergs-Saull, A; et al. |
1 March 2019 | Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT
| Clare, L; Kudlicka, A; Oyebode, JR; et al. |
15 March 2019 | Goal-oriented cognitive rehabilitation in early-stage Alzheimer's disease: a multi-centre single-blind randomised controlled trial (GREAT)
| Clare, L; Kudlicka, A; Oyebode, JR; et al. |
29 June 2022 | How do electronic risk assessment tools affect the communication and understanding of diagnostic uncertainty in the primary care consultation? A systematic review and thematic synthesis.
| Burns, A; Donnelly, B; Feyi-Waboso, J; et al. |
12 November 2021 | Impact of COVID-19 on ‘living well’ with mild-to-moderate dementia in the community: findings from the IDEAL cohort
| Clare, L; Martyr, A; Gamble, LD; et al. |
19 January 2021 | Increasing skeletal muscle carnitine content in older individuals increases whole-body fat oxidation during moderate-intensity exercise
| Chee, C; Shannon, CE; Burns, A; et al. |
17 November 2020 | Mild Cognitive Impairment: the Manchester Consensus
| Dunne, RA; Aarsland, D; O'Brien, JT; et al. |
9 March 2022 | Minimal Impact of COVID-19 Pandemic on the Mental Health and Wellbeing of People Living With Dementia: Analysis of Matched Longitudinal Data From the IDEAL Study
| Sabatini, S; Bennett, HQ; Martyr, A; et al. |
18 November 2019 | Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: A randomized clinical trial
| Howard, R; Zubko, O; Bradley, R; et al. |
31 October 2018 | MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR)
| Kessler, DS; McNeill, SJ; Tallon, D; et al. |
31 October 2018 | MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR)
| Kessler, DS; McNeill, SJ; Tallon, D; et al. |
31 October 2018 | Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).
| Kessler, DS; MacNeill, SJ; Tallon, D; et al. |
1 April 2016 | Novel insight regarding the trajectory and time-course of immobilisation induced impairment of limb glucose uptake in healthy volunteers
| Burns, A; Nixon, A; Stephens, F; et al. |
22 January 2013 | A pilot randomised controlled trial of cognitive behavioural therapy for antenatal depression
| Burns, A; O'Mahen, H; Baxter, H; et al. |
1 April 2016 | Relative contribution of intramyocellular lipid to whole-body fat oxidation is reduced with age but subsarcolemmal lipid accumulation and insulin resistance are only associated with overweight individuals.
| Chee, C; Shannon, CE; Burns, A; et al. |
20 January 2023 | Workload and workflow implications associated with the use of electronic clinical decision support tools used by health professionals in general practice: a scoping review
| Fletcher, E; Burns, A; Wiering, B; et al. |